(T44.8) Poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified

More details coming soon

Icon
140 805 in individuals diagnosis poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified confirmed

Diagnosis poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified is diagnosed Women are 11.20% more likely than Men

62 514

Men receive the diagnosis poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified

0 (less than 0.1%)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
78 291

Women receive the diagnosis poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified - Men and Women aged 0-5

Icon
In Men diagnosis is most often set at age 0-89
Icon
Less common in men the disease occurs at Age 90-95+Less common in women the disease occurs at Age 95+
Icon
In Women diagnosis is most often set at age 0-94

Disease Features poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified

Icon
Absence or low individual and public risk
Icon

Poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified - what does this mean

Poisoning from centrally acting and adrenergic-neuron-blocking agents occurs when a person is exposed to a substance that blocks the transmission of signals from the brain to the adrenergic neurons, resulting in an inability to regulate the body's physiological processes. this can lead to a variety of symptoms, including dizziness, confusion, drowsiness, and difficulty breathing.

What happens during the disease - poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified

Poisoning caused by centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified, is a serious medical condition that can cause a wide range of symptoms. these agents interfere with the normal functioning of the central nervous system and the autonomic nervous system, leading to a decrease in heart rate, blood pressure, and respiration. additionally, these agents can cause confusion, dizziness, and difficulty breathing. treatment is usually supportive and may include the administration of anticonvulsants, beta-blockers, or other medications depending on the severity of the poisoning.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical Examination
  • Blood Tests
  • Urine Tests
  • Imaging Tests (X-ray, CT scan, MRI)
  • Toxicology Screening
  • Electrocardiogram (ECG)
  • Electroencephalogram (EEG)
  • Liver Function Tests
  • Thyroid Function Tests
  • Pulmonary Function Tests
  • Skin Tests
  • Brain Scan

Treatment and Medical Assistance

Main Goal: To reduce the effects of poisoning caused by centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified.
  • Administering medications to reduce the effects of the poison
  • Monitoring vital signs
  • Providing supportive care, such as intravenous fluids
  • Providing oxygen therapy
  • Administering activated charcoal to reduce absorption of the poison
  • Administering antidotes to counteract the poison, if available
Icon
6 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Poisoning: centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified - Prevention

The best way to prevent poisoning from centrally acting and adrenergic-neuron-blocking agents is to avoid contact with these agents and to follow safety protocols when handling them. this includes wearing protective clothing, using proper ventilation and storing the agents in a secure location. additionally, it is important to be aware of any potential side effects and seek medical attention immediately if any symptoms of poisoning are experienced.

Specified forms of the disease

(M32.0) Drug-induced systemic lupus erythematosus
(M32.1+) Systemic lupus erythematosus with organ or system involvement
(M32.8) Other forms of systemic lupus erythematosus
(M32.9) Systemic lupus erythematosus, unspecified